TERUMO CORP/ADR (OTCMKTS:TRUMY) Cut to “Hold” at ValuEngine

ValuEngine lowered shares of TERUMO CORP/ADR (OTCMKTS:TRUMY) from a buy rating to a hold rating in a research report report published on Tuesday, April 9th, ValuEngine reports.

Separately, Zacks Investment Research upgraded shares of TERUMO CORP/ADR from a sell rating to a hold rating in a research report on Thursday, March 14th.

Shares of TERUMO CORP/ADR stock traded up $0.16 during mid-day trading on Tuesday, reaching $29.54. 471 shares of the stock were exchanged, compared to its average volume of 444. TERUMO CORP/ADR has a fifty-two week low of $25.60 and a fifty-two week high of $31.92.

TERUMO CORP/ADR Company Profile

Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems.

Recommended Story: Hedge Funds Explained

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for TERUMO CORP/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TERUMO CORP/ADR and related companies with MarketBeat.com's FREE daily email newsletter.